Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines

Noam Van Der Walde; Reshma Jagsi; Efrat Dotan; Joel Baumgartner; Ilene S. Browner; Peggy Burhenn; Harvey Jay Cohen; Barish H. Edil; Beatrice Edwards; Martine Extermann; Apar Kishor P. Ganti; Cary Gross; Joleen Hubbard; Nancy L. Keating; Beatriz Korc-Grodzicki; June M. McKoy; Bruno C. Medeiros; Ewa Mrozek; Tracey O'Connor; Hope S. Rugo; Randall W. Rupper; Dale Shepard; Rebecca A. Silliman; Derek L. Stirewalt; William P. Tew; Louise C. Walter; Tanya Wildes; Mary Anne Bergman; Hema Sundar; Arti Hurria

doi:10.6004/jnccn.2016.0146

Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines

Noam Van Der Walde, Reshma Jagsi, Efrat Dotan, Joel Baumgartner, Ilene S. Browner, Peggy Burhenn, Harvey Jay Cohen, Barish H. Edil, Beatrice Edwards, Martine Extermann, Apar Kishor P. Ganti, Cary Gross, Joleen Hubbard, Nancy L. Keating, Beatriz Korc-Grodzicki, June M. McKoy, Bruno C. Medeiros, Ewa Mrozek, Tracey O'Connor, Hope S. RugoRandall W. Rupper, Dale Shepard, Rebecca A. Silliman, Derek L. Stirewalt, William P. Tew, Louise C. Walter, Tanya Wildes, Mary Anne Bergman, Hema Sundar, Arti Hurria

School of Medicine

Research output: Contribution to journal › Review article › peer-review

46 Scopus citations

Abstract

Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.

Original language	English (US)
Pages (from-to)	1357-1370
Number of pages	14
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	14
Issue number	11
DOIs	https://doi.org/10.6004/jnccn.2016.0146
State	Published - Nov 1 2016

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2016.0146

Cite this

Van Der Walde, N., Jagsi, R., Dotan, E., Baumgartner, J., Browner, I. S., Burhenn, P., Cohen, H. J., Edil, B. H., Edwards, B., Extermann, M., Ganti, A. K. P., Gross, C., Hubbard, J., Keating, N. L., Korc-Grodzicki, B., McKoy, J. M., Medeiros, B. C., Mrozek, E., O'Connor, T., ... Hurria, A. (2016). Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 14(11), 1357-1370. https://doi.org/10.6004/jnccn.2016.0146

Van Der Walde, N, Jagsi, R, Dotan, E, Baumgartner, J, Browner, IS, Burhenn, P, Cohen, HJ, Edil, BH, Edwards, B, Extermann, M, Ganti, AKP, Gross, C, Hubbard, J, Keating, NL, Korc-Grodzicki, B, McKoy, JM, Medeiros, BC, Mrozek, E, O'Connor, T, Rugo, HS, Rupper, RW, Shepard, D, Silliman, RA, Stirewalt, DL, Tew, WP, Walter, LC, Wildes, T, Bergman, MA, Sundar, H & Hurria, A 2016, 'Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 11, pp. 1357-1370. https://doi.org/10.6004/jnccn.2016.0146

@article{e1f98dc7e0c4481ebe09741fff6c275d,

title = "Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines",

abstract = "Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.",

author = "{Van Der Walde}, Noam and Reshma Jagsi and Efrat Dotan and Joel Baumgartner and Browner, {Ilene S.} and Peggy Burhenn and Cohen, {Harvey Jay} and Edil, {Barish H.} and Beatrice Edwards and Martine Extermann and Ganti, {Apar Kishor P.} and Cary Gross and Joleen Hubbard and Keating, {Nancy L.} and Beatriz Korc-Grodzicki and McKoy, {June M.} and Medeiros, {Bruno C.} and Ewa Mrozek and Tracey O'Connor and Rugo, {Hope S.} and Rupper, {Randall W.} and Dale Shepard and Silliman, {Rebecca A.} and Stirewalt, {Derek L.} and Tew, {William P.} and Walter, {Louise C.} and Tanya Wildes and Bergman, {Mary Anne} and Hema Sundar and Arti Hurria",

year = "2016",

month = nov,

day = "1",

doi = "10.6004/jnccn.2016.0146",

language = "English (US)",

volume = "14",

pages = "1357--1370",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "11",

}

TY - JOUR

T1 - Older adult oncology, version 2.2016

T2 - Featured updates to the NCCN guidelines

AU - Van Der Walde, Noam

AU - Jagsi, Reshma

AU - Dotan, Efrat

AU - Baumgartner, Joel

AU - Browner, Ilene S.

AU - Burhenn, Peggy

AU - Cohen, Harvey Jay

AU - Edil, Barish H.

AU - Edwards, Beatrice

AU - Extermann, Martine

AU - Ganti, Apar Kishor P.

AU - Gross, Cary

AU - Hubbard, Joleen

AU - Keating, Nancy L.

AU - Korc-Grodzicki, Beatriz

AU - McKoy, June M.

AU - Medeiros, Bruno C.

AU - Mrozek, Ewa

AU - O'Connor, Tracey

AU - Rugo, Hope S.

AU - Rupper, Randall W.

AU - Shepard, Dale

AU - Silliman, Rebecca A.

AU - Stirewalt, Derek L.

AU - Tew, William P.

AU - Walter, Louise C.

AU - Wildes, Tanya

AU - Bergman, Mary Anne

AU - Sundar, Hema

AU - Hurria, Arti

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.

AB - Cancer is the leading cause of death in older adults aged 60 to 79 years. Older patients with good performance status are able to tolerate commonly used treatment modalities as well as younger patients, particularly when adequate supportive care is provided. For older patients who are able to tolerate curative treatment, options include surgery, radiation therapy (RT), chemotherapy, and targeted therapies. RT can be highly effective and well tolerated in carefully selected patients, and advanced age alone should not preclude the use of RT in older patients with cancer. Judicious application of advanced RT techniques that facilitate normal tissue sparing and reduce RT doses to organs at risk are important for all patients, and may help to assuage concerns about the risks of RT in older adults. These NCCN Guidelines Insights focus on the recent updates to the 2016 NCCN Guidelines for Older Adult Oncology specific to the use of RT in the management of older adults with cancer.

UR - http://www.scopus.com/inward/record.url?scp=84994626854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994626854&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2016.0146

DO - 10.6004/jnccn.2016.0146

M3 - Review article

C2 - 27799507

AN - SCOPUS:84994626854

SN - 1540-1405

VL - 14

SP - 1357

EP - 1370

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 11

ER -

Older adult oncology, version 2.2016: Featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this